Kesatuan Eropah - Romania - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - attenuated feline rhinotracheitis herpesvirus (fhv f2 strain), inactivated feline calicivirosis antigens (fcv 431 and g1 strains), attenuated feline panleucopenia virus (pli iv), felv recombinant canarypox virus (vcp97) - produsele imunologice pentru felidae, - pisici - active immunisation of cats aged 8 weeks and older:against feline viral rhinotracheitis to reduce clinical signs;against calicivirus infection to reduce clinical signs ;against feline panleucopenia to prevent mortality and clinical signs;against leukaemia to prevent persistent viraemia and clinical signs of the related disease. onsets of immunity are 1 week after primary vaccination course for rhinotracheitis, calicivirus and panleucopenia components, and 2 weeks after primary vaccination course for feline leukaemia component. the duration of immunity is one year after the last re-vaccination for the feline leukaemia component, and one year after primary vaccination course and three years after the last re-vaccination for the rhinotracheitis, calicivirosis and panleucopenia components.

Kesatuan Eropah - Romania - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - attenuated feline rhinotracheitis herpesvirus (fhv f2 strain), inactivated feline calicivirosis antigens (fcv 431 and g1 strains), attenuated feline panleucopenia virus (pli iv), felv recombinant canarypox virus (vcp97), attenuated chlamydophila felis (905 strain) - produsele imunologice pentru felidae, - pisici - active immunisation of cats aged 8 weeks and older:against feline viral rhinotracheitis to reduce clinical signs;against calicivirus infection to reduce clinical signs;against chlamydophila felis infection to reduce clinical signs;against feline panleucopenia to prevent mortality and clinical signs;against leukaemia to prevent persistent viraemia and clinical signs of the related disease. onsets of immunity are 1 week after primary vaccination course for rhinotracheitis, calicivirus, chlamydophila felis and panleucopenia components, and 2 weeks after primary vaccination course for feline leukaemia component. the duration of immunity is one year after the last re-vaccination for the chlamydiosis and feline leukaemia components, and one year after primary vaccination course and three years after the last re-vaccination for the rhinotracheitis, calicivirosis and panleucopenia components.

Moldova - Romania - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

egis pharmaceuticals plc - quetiapinum - comprimate filmate - 300 mg

Moldova - Romania - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

egis pharmaceuticals plc - quetiapinum - comprimate filmate - 100 mg

Moldova - Romania - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

egis pharmaceuticals plc - quetiapinum - comprimate filmate - 150 mg

Moldova - Romania - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

egis pharmaceuticals plc - quetiapinum - comprimate filmate - 200 mg

Moldova - Romania - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

egis pharmaceuticals plc - quetiapinum - comprimate filmate - 25 mg

Moldova - Romania - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

gedeon richter plc - ethinylestradiolum + levonorgestrelum - comprimate filmate - 0,03 mg + 0,05 mg; 0,04 mg + 0,075 mg; 0,03 mg + 0,125 mg

Moldova - Romania - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

medac gmbh - asparaginasum - pulbere pentru solutie injectabila - 10000 ui

Moldova - Romania - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

ficotehfarm srl - soluţie alcoolică inventia se refera - ovule - 10 mg